Dan Schell articles

  1. Making Sense Of New Accounting And Financial Reporting Changes 5/31/2019

    A summary of some key sections of version 10 of Deloitte’s Life Sciences Accounting And Financial Reporting Update—Including Interpretive Guidance.

  2. The Impact Of A Biotech CEO On Company Growth 5/1/2019

    An inside look at how CEO Yuval Cohen communicates and interacts with employees at Corbus Pharmaceuticals, and how all of that affects the company’s culture.

  3. The Rollercoaster Ride Of A Biotech CEO 4/1/2019

    Sam Cobb, managing director and CEO of Australian biotech AdAlta, talks about how the company has struggled to procure funding over the years and the strategies they employed to finally get listed on the Australian Securities Exchange.

  4. Others Talk About Creating Good Stories; We Write Them 9/28/2018

    Good storytelling is the crux of every article in Life Science leader, and our October issue is no exception. Here are a few examples of what not to miss in our next issue.

  5. The Appeal Of A Good Underdog Story 8/22/2018

    Like many people, I’ve always loved a good underdog story, and recently Life Science Leader has had some good ones. We also have a great CEO Corner coming up in our September issue that talks about what it’s like going from being a VC to founding and running a biopharma.